---
title: "P-21 Amidate: Dosing &amp; Vendor Prices | BodyHackGuide"
description: "P-21 Amidate: dosing protocols, mechanism &amp; side effects, 1 PubMed results. Compare current vendor prices."
lang: en
json-ld: |
  [
    {
      "@context": "https://schema.org",
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.bodyhackguide.co/"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Compounds",
          "item": "https://www.bodyhackguide.co/compare"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "P-21 Amidate"
        }
      ]
    },
    {
      "@context": "https://schema.org",
      "@type": "MedicalWebPage",
      "name": "P-21 Amidate",
      "description": "P-21 Amidate is the amide-modified variant of P-21, the cyclic dipeptide derived from Selank. The C-terminal amidation is reported to further improve oral bioavailability and metabolic stability beyond what the cyclic structure alone provides. The practical positioning: P-21 is already orally active; the amidate variant pushes that further, with vendor and community reports of higher subjective potency at equivalent doses. Peer-reviewed comparative data for the amidate form remains thin — most published P-21 research uses the unmodified cyclic form.",
      "lastReviewed": "2026-09-14T19:40:22.325Z",
      "url": "https://www.bodyhackguide.co/compound/p21-amidate",
      "author": {
        "@type": "Person",
        "name": "BioChonch",
        "url": "https://www.bodyhackguide.co/about",
        "jobTitle": "Founder & Lead Researcher",
        "sameAs": [
          "https://reddit.com/r/BodyHackGuide",
          "https://reddit.com/r/BrainHackGuide",
          "https://reddit.com/r/Biohackingher"
        ],
        "worksFor": {
          "@type": "Organization",
          "name": "BodyHackGuide",
          "url": "https://www.bodyhackguide.co"
        }
      },
      "reviewedBy": {
        "@type": "Person",
        "name": "BioChonch",
        "url": "https://www.bodyhackguide.co/about",
        "jobTitle": "Founder & Lead Researcher",
        "sameAs": [
          "https://reddit.com/r/BodyHackGuide",
          "https://reddit.com/r/BrainHackGuide",
          "https://reddit.com/r/Biohackingher"
        ],
        "worksFor": {
          "@type": "Organization",
          "name": "BodyHackGuide",
          "url": "https://www.bodyhackguide.co"
        }
      },
      "publisher": {
        "@type": "Organization",
        "name": "BodyHackGuide",
        "url": "https://www.bodyhackguide.co"
      },
      "mainContentOfPage": {
        "@type": "WebPageElement",
        "cssSelector": "main"
      },
      "about": {
        "@type": "Drug",
        "name": "P-21 Amidate",
        "alternateName": [
          "P21 Amide",
          "P-21 Amide",
          "P-21-NH2",
          "Cyclo-Pro-Gly-Amide"
        ],
        "description": "P-21 Amidate is the amide-modified variant of P-21, the cyclic dipeptide derived from Selank. The C-terminal amidation is reported to further improve oral bioavailability and metabolic stability beyond what the cyclic structure alone provides. The practical positioning: P-21 is already orally active; the amidate variant pushes that further, with vendor and community reports of higher subjective potency at equivalent doses. Peer-reviewed comparative data for the amidate form remains thin — most published P-21 research uses the unmodified cyclic form.",
        "activeIngredient": "P-21 Amidate",
        "mechanismOfAction": "Mechanism (P-21 / P021): P-21 is a small-molecule mimetic of a biologically active region of human ciliary neurotrophic factor (CNTF) - an adamantylated peptide amide, Ac-DGGL(A)G-NH2. Its reported actions come from preclinical (rodent) studies: Increases brain-derived neurotrophic factor (BDNF) expression by inhibiting the leukemia inhibitory factor (LIF) signaling pathway [PMID:27400746] Enhances hippocampal (dentate gyrus) neurogenesis and synaptic plasticity [PMID:25046994] Lowers tau hyperphosphorylation indirectly: increased BDNF reduces glycogen synthase kinase-3 (GSK-3, a major tau kinase) activity [PMID:27400746] Blood-brain-barrier permeable and orally bioavailable, unlike native CNTF or BDNF [PMID:27400746] On the \"Amidate\" label: Base P021 is already C-terminally amidated (the -NH2 in Ac-DGGL(A)G-NH2). Vendor claims that \"P-21 Amidate\" is a chemically distinct, more stable, or more potent form than standard P-21 are unverified marketing differentiation and are not supported by the published literature. All evidence is from animal models - there are no human pharmacokinetic, efficacy, or safety studies. Research use only.",
        "legalStatus": "Not approved for human use (research chemical)",
        "warning": "For research purposes only. Not for human consumption."
      }
    },
    {
      "@context": "https://schema.org",
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "What is P-21 Amidate used for in research?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "P-21 Amidate is the amide-modified variant of P-21, the cyclic dipeptide derived from Selank. The C-terminal amidation is reported to further improve oral bioavailability and metabolic stability beyond what the cyclic structure alone provides. The practical positioning: P-21 is already orally active; the amidate variant pushes that further, with vendor and community reports of higher subjective potency at equivalent doses. Peer-reviewed comparative data for the amidate form remains thin — most published P-21 research uses the unmodified cyclic form."
          }
        },
        {
          "@type": "Question",
          "name": "What forms does P-21 Amidate come in?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "P-21 Amidate is available in vials, capsules, and sprays forms."
          }
        },
        {
          "@type": "Question",
          "name": "How much does P-21 Amidate cost?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Pricing varies by vendor and form."
          }
        },
        {
          "@type": "Question",
          "name": "How do I compare P-21 Amidate vendors?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Compare prices, payment methods, shipping, and COA scores across 0 vendors."
          }
        }
      ]
    },
    {
      "@context": "https://schema.org",
      "@type": "Organization",
      "@id": "https://www.bodyhackguide.co#organization",
      "name": "BodyHackGuide",
      "alternateName": "BHG",
      "url": "https://www.bodyhackguide.co",
      "logo": {
        "@type": "ImageObject",
        "url": "https://www.bodyhackguide.co/logo.png",
        "width": 512,
        "height": 512
      },
      "description": "Evidence-based research reference for peptides and nootropics. 124+ compound profiles, interactive dosing calculators, vendor price comparisons, and trust-scored vendor reviews scored on a public, reproducible methodology applied to every vendor. BodyHackGuide and BHG Labs share common ownership, and we earn a commission on purchases through our links.",
      "foundingDate": "2024",
      "founder": {
        "@id": "https://www.bodyhackguide.co/about#person"
      },
      "sameAs": [
        "https://reddit.com/r/BodyHackGuide",
        "https://reddit.com/r/BrainHackGuide",
        "https://reddit.com/r/Biohackingher",
        "https://discord.gg/Mhq5UdRYBA"
      ],
      "knowsAbout": [
        "Peptide research",
        "Nootropic research",
        "Biohacking",
        "Compound dosing",
        "Vendor transparency"
      ],
      "publishingPrinciples": "https://www.bodyhackguide.co/editorial-standards",
      "ethicsPolicy": "https://www.bodyhackguide.co/editorial-standards",
      "diversityPolicy": "https://www.bodyhackguide.co/editorial-standards"
    }
  ]
---

[Skip to content](#main-content)

## Research Use Only

This site is an **educational resource** for research compounds. We do **not endorse** human consumption of any compound. BodyHackGuide and **BHG Labs share common ownership**; we rank every vendor on the same public methodology, and we earn a commission on purchases through our links. By entering, you confirm you are **21 years of age or older** and agree to our [Terms](/terms) & [Privacy Policy](/privacy).

I'm 21+, enter siteLeave site

  

[![BodyHackGuide](/assets/bodyhackguide-logo-DOzZNUyh.webp)BodyHackGuide ](/)

[Compare](/compare)[Wiki](/wiki)[Vendors](/vendors)[Deals](/deals)[Stacks](/stack-builder)[Nootropics](/nootropics)[Tools](/tools)

Learn

Community

Search ⌘K

[Sign In](/auth?returnTo=%2Fcompound%2Fp21-amidate)

Compare notes with other researchers. Join [r/BodyHackGuide](https://reddit.com/r/bodyhackguide) 

1.  [Home](/)

3.  [Compounds](/compare)

5.  P-21 Amidate 

[🛒  Where to buy P-21 Amidate](/buy/p21-amidate)[🏷️  P-21 Amidate coupon codes](/coupons/p21-amidate)[📋  P-21 Amidate protocol](/protocol/p21-amidate)[🔄  Alternatives to P-21 Amidate](/alternatives-to/p21-amidate)[⚠️  P-21 Amidate side effects](/side-effects/p21-amidate)

1.  [Home](/)

3.  [Compounds](/compare)

5.  P-21 Amidate 

# P-21 Amidate

Nootropic Peptide Preclinical 

Download  PDF

Also known as: P21 Amide, P-21 Amide, P-21-NH2, Cyclo-Pro-Gly-Amide 

P-21 Amidate is the amide-modified variant of P-21, the cyclic dipeptide derived from Selank. The C-terminal amidation is reported to further improve oral bioavailability and metabolic stability beyond what the cyclic structure alone provides. The practical positioning: P-21 is already orally active; the amidate variant pushes that further, with vendor and community reports of higher subjective potency at equivalent doses.

Half-Life:  No established human PK - unknown. P-21 (P021) is a preclinical compound; rodent studies used chronic oral or subcutaneous dosing and demonstrated oral bioavailability and blood-brain-barrier penetration, but no validated human half-life data exist. MW:  ~592.7 g/mol (free base; molecular formula C28H44N6O8) [1 PubMed Results](https://pubmed.ncbi.nlm.nih.gov/?term=P-21%20Amidate)

Last reviewed: Sep 13, 2026 

[

1

PubMed Results



](https://pubmed.ncbi.nlm.nih.gov/?term=P-21%20Amidate)[

Nootropic Peptide

Category



](/wiki#cat-nootropic-peptide)

Preclinical

Research Stage

OverviewChemical InfoDosing & ProtocolsInteractionsResearchCompare PricesRelated

## Overview

### At A Glance

Mechanism 

Mechanism (P-21 / P021):… 

Half-Life 

No established human PK - unknown. P-21 (P021) is a preclinical compound; rodent studies used chronic oral or subcutaneous dosing and demonstrated oral bioavailability and blood-brain-barrier penetration, but no validated human half-life data exist.

### Mechanism of Action

**Mechanism (P-21 / P021):**

P-21 is a small-molecule mimetic of a biologically active region of human ciliary neurotrophic factor (CNTF) - an adamantylated peptide amide, Ac-DGGL(A)G-NH2. Its reported actions come from preclinical (rodent) studies:

-   Increases brain-derived neurotrophic factor (BDNF) expression by inhibiting the leukemia inhibitory factor (LIF) signaling pathway \[PMID:27400746\]
-   Enhances hippocampal (dentate gyrus) neurogenesis and synaptic plasticity \[PMID:25046994\]
-   Lowers tau hyperphosphorylation indirectly: increased BDNF reduces glycogen synthase kinase-3 (GSK-3, a major tau kinase) activity \[PMID:27400746\]
-   Blood-brain-barrier permeable and orally bioavailable, unlike native CNTF or BDNF \[PMID:27400746\]

**On the "Amidate" label:** Base P021 is already C-terminally amidated (the -NH2 in Ac-DGGL(A)G-NH2). Vendor claims that "P-21 Amidate" is a chemically distinct, more stable, or more potent form than standard P-21 are unverified marketing differentiation and are not supported by the published literature.

All evidence is from animal models - there are no human pharmacokinetic, efficacy, or safety studies. Research use only.

### Overview

P-21 Amidate is the **amide-modified variant of [P-21](/compound/p21)**, the cyclic dipeptide derived from [Selank](/compound/selank). The C-terminal amidation is reported to further improve oral bioavailability and metabolic stability beyond what the cyclic structure alone provides.

The practical positioning: P-21 is already orally active; the amidate variant pushes that further, with vendor and community reports of higher subjective potency at equivalent doses. Peer-reviewed comparative data for the amidate form remains thin — most published P-21 research uses the unmodified cyclic form.

## Chemical Information

IUPAC Name

Not yet available 

CAS Number

Not yet available 

Molecular Formula

C7H11N3O2

Molecular Mass

592.69 g/mol

Amino Acid Sequence

Ac-DGGL(A)G-NH2

## Dosing & Protocols

### Dosing Summary

Dose

100-600 mcg/day

Route

Oral / Intranasal

Frequency

1-2x daily

Duration

14-30 day cycles

### Beginner Protocol

### Intermediate Protocol

### Advanced Protocol

### Stacking Notes

### Additional Dosage Notes

[Full P-21 Amidate Dosing Guide](/guides/dosage/p21-amidate) [Open Reconstitution Calculator](/tools/reconstitution)

### Unlock Dosing Protocols

Free account gets you:

-   View beginner, intermediate & advanced protocols 
-   See weight-based dosing calculations 
-   Access cycle length & frequency data 

[Create free account](/auth)[Sign in](/auth)

Join other researchers already signed up

## Research

[1 PubMed Results](https://pubmed.ncbi.nlm.nih.gov/?term=P-21%20Amidate)

### Key Research Findings

No human clinical trials have been conducted on P-21 (P021); the evidence base is entirely preclinical. In rodent models, chronic oral P021 increased BDNF, enhanced dentate-gyrus neurogenesis and synaptic plasticity, reduced tau hyperphosphorylation via decreased GSK-3 activity, and improved cognition - reported in a triple-transgenic Alzheimer's model \[PMID:25046994\] and an aged-rat cognitive-aging model \[PMID:24702821\], and reviewed for Alzheimer's drug development \[PMID:27400746\]. A 2024 study in a CDKL5-deficiency model showed in-vitro benefit but limited in-vivo effect, with no increase in brain BDNF in that model \[PMID:39592934\]. No human pharmacokinetic, efficacy, or safety data exist. Research use only.

[Browse Studies on PubMed](https://pubmed.ncbi.nlm.nih.gov/?term=P-21%20Amidate)

### Unlock Research Data

Free account gets you:

-   Browse PubMed study summaries 
-   See clinical trial phases & results 
-   Access mechanism of action details 

[Create free account](/auth)[Sign in](/auth)

Join other researchers already signed up

## Interactions

Interaction and contraindication data is being compiled for P-21 Amidate. Check back soon.

General Safety Note

Always consult a qualified healthcare professional before combining research compounds. Interactions may exist that are not yet documented.

[Sign in for alerts ](/auth)

No listings found for P-21 Amidate.

Get P-21 Amidate Price Drop Alerts

Set a target price and we'll notify you when any vendor drops below it.

[Sign in to set alerts](/auth)

### Sign in to leave a review

Reviews on BodyHackGuide are tied to verified user accounts and moderated before publishing. Sign in (free, no spam) to share your experience with P-21 Amidate.

[Sign in](/auth)

### Related Compounds

[View All](/wiki)

[

### Adalank

Nootropic Peptide Preclinical / Research compound 

Adalank is a hybrid research peptide combining structural elements of Adamax (the adamantyl-modified Semax analog) and Selank (the anxiolytic Pro-Gly-Pro tuftsin analog).

t½ The commonly cited ~72-hour "functional duration" is an unverified community/vendor claim, not a measured value - no pharmacokinetic study of Adalank has ever been run. The figure is extrapolated from parent Adamax marketing claims. Actual serum half-life is unknown; there is no published PK data.  200-1200 mcg per dose (intranasal or subcutaneous), 1-2x daily 

Preclinical View Profile 

](/compound/adalank)[

### Adamax

Nootropic Peptide Preclinical / Research compound 

Adamax is a synthetic nonapeptide (Ac-MEHFPGPAG-NH2) classified as a designer analog of Semax.

t½ No pharmacokinetic data. Community reports describe a subjectively long duration of effect (~2-3 days), supporting every-other-day or 3x/week dosing; serum half-life not characterized.  500-2000 mcg subcutaneous (community research dosing) 

Preclinical View Profile 

](/compound/adamax)[

### Cerebrolysin

Nootropic Peptide Clinical 

Cerebrolysin is a porcine brain-derived peptide complex developed by EVER Neuro Pharma (Austria) — a low-molecular-weight neurotrophic preparation containing a mixture of free amino acids and bioactive peptides extracted from purified pig brain proteins.

t½ ~2-4 hours (multi-component peptide mix) 

85 PubMed View Profile 

](/compound/cerebrolysin)[

### Cortexin

Nootropic Peptide Marketed in Russia/CIS (Geropharm); human clinical use with limited-quality evidence (small, mostly Russian-language studies; no Western RCT; not FDA/EMA approved) 

Cortexin is a purified peptide preparation extracted from cattle and pig cerebral cortex tissue — a low-molecular-weight neuropeptide complex used clinically in Russia and Eastern Europe for cognitive impairment, post-stroke recovery, encephalopathy, attention disorders, and pediatric developmental conditions. Like Cerebrolysin, Cortexin is positioned as a broad-spectrum neurotrophic preparation supplying bioactive peptides that mimic endogenous neurotrophic factors.

t½ ~2-3 hours (estimated from analog peptide preparations) 

18 PubMed View Profile 

](/compound/cortexin)[

### NA-Semax

Nootropic Peptide Preclinical 

NA-Semax is the N-acetyl-l-aspartyl variant of Semax — the original ACTH(4-7) Pro-Gly-Pro analog developed at the Russian Academy of Sciences in the 1990s.

t½ ~20-30 minutes (intranasal, estimated from analog data) 

3 PubMed View Profile 

](/compound/na-semax)[

### NA-Semax Amidate

Nootropic Peptide Preclinical 

NA-Semax Amidate is the C-terminally amidated NA-Semax — the carboxylic acid at the peptide's C-terminus is replaced with an amide group (-NH2), which is reported to further extend metabolic half-life by resisting carboxypeptidase cleavage in addition to the aminopeptidase resistance the N-acetyl group already provides. The practical effect is a peptide with dosing-frequency use: where standard Semax often requires 3-4 daily doses to maintain effect, NA-Semax Amidate is reported (in vendor monographs and community usage) to maintain subjective effects on a 1-2x daily schedule.

t½ ~30-45 minutes (estimated, longer than standard Semax) 

2 PubMed View Profile 

](/compound/na-semax-amidate)

[

View Full Dosage Guide →

Protocols, calculator & safety for P-21 Amidate



](/guides/dosage/p21-amidate)

### Research Score

60 

1 PubMed results

### Quality Indicators

Data Completeness

75% 

Description 

Mechanism of Action 

Chemical Data 

Dosing Protocols 

Safety Profile 

PubMed Results 

Interactions 

Vendor Listings 

Research Volume

1 PubMed results 

Limited research available

### Quick Facts

Half-Life

No established human PK - unknown. P-21 (P021) is a preclinical compound; rodent studies used chronic oral or subcutaneous dosing and demonstrated oral bioavailability and blood-brain-barrier penetration, but no validated human half-life data exist.

Molecular Weight

592.69 g/mol

Trial Phase

Preclinical

### Safety Profile

Moderate Risk 

Stop Use If

-   Pregnancy or breastfeeding
-   Known peptide allergy

[Full Dosage Guide](/guides/dosage/p21-amidate)[Calculate Your Dose](/tools/reconstitution)

Research Disclaimer

This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use.

## Frequently Asked Questions

What is P-21 Amidate used for in research?

P-21 Amidate is the **amide-modified variant of [P-21](/compound/p21)**, the cyclic dipeptide derived from [Selank](/compound/selank). The C-terminal amidation is reported to further improve oral bioavailability and metabolic stability beyond what the cyclic structure alone provides.

The practical positioning: P-21 is already orally active; the amidate variant pushes that further, with vendor and community reports of higher subjective potency at equivalent doses. Peer-reviewed comparative data for the amidate form remains thin — most published P-21 research uses the unmodified cyclic form.

What forms does P-21 Amidate come in?

P-21 Amidate is available in vials, capsules, and sprays forms.

How much does P-21 Amidate cost?

Pricing varies by vendor and form.

How do I compare P-21 Amidate vendors?

Compare prices, payment methods, shipping, and COA scores across 0 vendors.

## Research Tools

[

### Peptide Calculator

Reconstitution & syringe units



](/tools/reconstitution)[

### Reconstitution Guide

How to mix, step by step



](/guides/how-to-reconstitute-peptides)[

### Nasal Spray Calc

mL per actuation



](/tools/intranasal)[

### Half-Life Visualizer

Decay curves



](/tools/halflife)

## Related Compounds

[View All](/wiki)

[

### Adalank

Nootropic Peptide Preclinical / Research compound 

Adalank is a hybrid research peptide combining structural elements of Adamax (the adamantyl-modified Semax analog) and Selank (the anxiolytic Pro-Gly-Pro tuftsin analog).

t½ The commonly cited ~72-hour "functional duration" is an unverified community/vendor claim, not a measured value - no pharmacokinetic study of Adalank has ever been run. The figure is extrapolated from parent Adamax marketing claims. Actual serum half-life is unknown; there is no published PK data.  200-1200 mcg per dose (intranasal or subcutaneous), 1-2x daily 

Preclinical View Profile 

](/compound/adalank)[

### Adamax

Nootropic Peptide Preclinical / Research compound 

Adamax is a synthetic nonapeptide (Ac-MEHFPGPAG-NH2) classified as a designer analog of Semax.

t½ No pharmacokinetic data. Community reports describe a subjectively long duration of effect (~2-3 days), supporting every-other-day or 3x/week dosing; serum half-life not characterized.  500-2000 mcg subcutaneous (community research dosing) 

Preclinical View Profile 

](/compound/adamax)[

### Cerebrolysin

Nootropic Peptide Clinical 

Cerebrolysin is a porcine brain-derived peptide complex developed by EVER Neuro Pharma (Austria) — a low-molecular-weight neurotrophic preparation containing a mixture of free amino acids and bioactive peptides extracted from purified pig brain proteins.

t½ ~2-4 hours (multi-component peptide mix) 

85 PubMed View Profile 

](/compound/cerebrolysin)[

### Cortexin

Nootropic Peptide Marketed in Russia/CIS (Geropharm); human clinical use with limited-quality evidence (small, mostly Russian-language studies; no Western RCT; not FDA/EMA approved) 

Cortexin is a purified peptide preparation extracted from cattle and pig cerebral cortex tissue — a low-molecular-weight neuropeptide complex used clinically in Russia and Eastern Europe for cognitive impairment, post-stroke recovery, encephalopathy, attention disorders, and pediatric developmental conditions. Like Cerebrolysin, Cortexin is positioned as a broad-spectrum neurotrophic preparation supplying bioactive peptides that mimic endogenous neurotrophic factors.

t½ ~2-3 hours (estimated from analog peptide preparations) 

18 PubMed View Profile 

](/compound/cortexin)[

### NA-Semax

Nootropic Peptide Preclinical 

NA-Semax is the N-acetyl-l-aspartyl variant of Semax — the original ACTH(4-7) Pro-Gly-Pro analog developed at the Russian Academy of Sciences in the 1990s.

t½ ~20-30 minutes (intranasal, estimated from analog data) 

3 PubMed View Profile 

](/compound/na-semax)[

### NA-Semax Amidate

Nootropic Peptide Preclinical 

NA-Semax Amidate is the C-terminally amidated NA-Semax — the carboxylic acid at the peptide's C-terminus is replaced with an amide group (-NH2), which is reported to further extend metabolic half-life by resisting carboxypeptidase cleavage in addition to the aminopeptidase resistance the N-acetyl group already provides. The practical effect is a peptide with dosing-frequency use: where standard Semax often requires 3-4 daily doses to maintain effect, NA-Semax Amidate is reported (in vendor monographs and community usage) to maintain subjective effects on a 1-2x daily schedule.

t½ ~30-45 minutes (estimated, longer than standard Semax) 

2 PubMed View Profile 

](/compound/na-semax-amidate)

Free 2026 Peptide Cheat Sheet (PDF)

Reconstitution math, concentration charts, half-lives, and vendor links. The reference we wish we had on day one.

[Download Free](/guides/peptide-cheat-sheet-download?utm_source=compound-p21-amidate)

### Need bloodwork before starting?

Full hormone + metabolic panels from Anabolic Insights. Code CHONCH  for first-order discount.

[Order Bloodwork](https://anabolicinsights.ai/?ref=nwm2zjb)

![BodyHackGuide](/assets/bodyhackguide-logo-DOzZNUyh.webp)

### BodyHackGuide

Your biohacking research hub: compound pricing, brain health protocols, dosing tools, and vendor reviews.

[support@bodyhackguide.co](mailto:support@bodyhackguide.co)

[](https://discord.gg/Mhq5UdRYBA)[](https://reddit.com/r/BodyHackGuide)

Explore

#### Explore

-   [Compare prices](/compare)
-   [Research suppliers](/vendors)
-   [Deals](/deals)
-   [Coupons](/coupons)
-   [Nootropics](/nootropics)
-   [Brain health](/brain-health)
-   [Blog](/blog)
-   [Guides](/guides)

Tools

#### Tools

-   [Reconstitution](/tools/reconstitution)
-   [Half-life visualizer](/tools/halflife)
-   [COA lookup](/tools/coa)
-   [Cost calculator](/tools/cost-calculator)
-   [Stack builder](/stack-builder)
-   [All tools →](/tools)

Trust & vendors

#### Trust & vendors

-   [Vendor directory](/vendors)
-   [Trust scorecard](/vendors/scorecard)
-   [Vendor trust badge](/vendors/get-vetted)
-   [Scoring methodology](/vendors/methodology)
-   [Peptide cheatsheet](/guides/peptide-cheat-sheet-download)

Company

#### Company

-   [About](/about)
-   [Affiliate disclosure](/affiliate-disclosure)
-   [Editorial standards](/editorial-standards)
-   [Creators](/creators)
-   [Coaches](/coaches)
-   [Privacy](/privacy)
-   [Terms](/terms)
-   [Full site directory →](/site-directory)

**Ownership & Affiliate Disclosure:** BodyHackGuide and BHG Labs share common ownership. We rank every vendor on the same public, reproducible [methodology](/vendors/methodology), and we earn a commission from purchases made through our links at no extra cost to you. Full details in our [affiliate disclosure](/affiliate-disclosure).

**Research Disclaimer:** All compounds listed are for laboratory and research purposes only. Not for human consumption. This site does not sell, distribute, or promote any products. Always consult a qualified healthcare professional and comply with local regulations.

© 2026 BodyHackGuide. All rights reserved. · [Terms](/terms) · [Privacy](/privacy)

hi 👋